Stockscreener 앱 받기
4.78
2.58%
0.12
시간 외 거래:
4.78
전일 마감가:
$4.66
열려 있는:
$4.73
하루 거래량:
793.36K
Relative Volume:
1.08
시가총액:
$617.30M
수익:
$201.49M
순이익/손실:
$-66.54M
주가수익비율:
-9.1976
EPS:
-0.5197
순현금흐름:
$-8.88M
1주 성능:
+4.60%
1개월 성능:
+5.52%
6개월 성능:
+19.20%
1년 성능:
+25.79%
1일 변동 폭
$4.73
$4.97
1주일 범위
$4.355
$4.97
52주 변동 폭
$2.37
$6.18
Cytek Biosciences Inc Stock (CTKB) Company Profile
명칭
Cytek Biosciences Inc
전화
(877) 922-9835
주소
47215 LAKEVIEW BOULEVARD, FREMONT
Compare CTKB vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CTKB
Cytek Biosciences Inc
|
4.78 | 601.80M | 201.49M | -66.54M | -8.88M | -0.5197 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Cytek Biosciences Inc Stock (CTKB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 재개 | Morgan Stanley | Equal-Weight |
| 2025-05-09 | 다운그레이드 | TD Cowen | Buy → Hold |
| 2025-01-31 | 다운그레이드 | Goldman | Buy → Sell |
| 2023-12-14 | 개시 | Stephens | Overweight |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
모두보기
Cytek Biosciences Inc 주식(CTKB)의 최신 뉴스
New Cytek Biosciences kit aims to boost high-resolution T cell analysis - Traders Union
Cytek Biosciences (NASDAQ: CTKB) details 2026 votes on board, pay and auditor - Stock Titan
CTKB Technical Analysis | Trend, Signals & Chart Patterns | CYTEK BIOSCIENCES INC (NASDAQ:CTKB) - ChartMill
Cytek Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026 - 富途牛牛
Attachment - GlobeNewswire
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates - MSN
Cytek Biosciences outlines $205M–$212M 2026 revenue target amid record Q4 and growth in recurring revenue - MSN
Cytek Biosciences sets May 7 webcast for Q1 2026 results - Stock Titan
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Cytek Biosciences unveils AI-driven single-cell imaging webinar on stem cell heterogeneity - Traders Union
Is Cytek (CTKB) stock underpriced in the market (-1.08%) 2026-04-20Elite Trading Signals - Cổng thông tin điện tử Tỉnh Sơn La
Attendees at ImmunologyAAI 109th meeting explore Cytek Biosciences new technology offerings - Traders Union
Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 27.93% Potential Upside for Investors - DirectorsTalk Interviews
249,812 Shares in Cytek Biosciences, Inc. $CTKB Purchased by Tudor Investment Corp ET AL - MarketBeat
Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System Updates - Yahoo Finance
Cytek Biosciences unveils 21-color T-cell kit to boost immunoprofiling workflows - Traders Union
Aug Action: Can Cytek Biosciences Inc sustain its profitabilityMarket Growth Summary & Weekly Watchlist of Top Performers - baoquankhu1.vn
Millennium Group reports 6.64M shares in Cytek Biosciences (CTKB) - Stock Titan
Cytek Biosciences streamlines drop charge optimization for small sample workflows - Traders Union
Stock Market Recap: Is Cytek Biosciences Inc stock showing strong momentumTrade Performance Summary & Fast Entry High Yield Stock Tips - baoquankhu1.vn
How does currency impact Cytek (CTKB) Stock | Price at $4.59, Down 0.22%Viral Momentum Stocks - Newser
Is Cytek (CTKB) Stock Near Support | Price at $4.58, Up 1.10%Elite Trading Signals - Newser
Cytek Biosciences, Inc. (8EQ.F) stock price, news, quote and history - Yahoo Finance UK
Tudor Investment Corp ET AL Invests $867,000 in Cytek Biosciences, Inc. $CTKB - MarketBeat
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives $5.38 Consensus PT from Analysts - Defense World
Cytek Biosciences, Inc. (NASDAQ:CTKB) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Vanguard realignment leaves Cytek (NASDAQ: CTKB) ownership at 0 after amendment - Stock Titan
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - sahmcapital.com
EPS Watch: What is the Moat Score of Cytek Biosciences Inc2026 Rallies & Smart Allocation Stock Reports - baoquankhu1.vn
Tranche Update on Cytek Biosciences, Inc.'s Equity Buyback Plan announced on December 30, 2024. - marketscreener.com
CTKB Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Cytek Biosciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Topline Capital Management LLC Has $24.10 Million Position in Cytek Biosciences, Inc. $CTKB - MarketBeat
US Stocks Recap: How does Cytek Biosciences Inc compare to its peersMarket Growth Report & Real-Time Market Sentiment Reports - baoquankhu1.vn
Cytek Biosciences (CTKB) director converts 6,107 RSUs into common stock - Stock Titan
Cytek Biosciences (CTKB) CLO receives new options, 226,453 RSUs and stock from vesting - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) SVP granted options, RSUs and sees RSU vesting - Stock Titan
Cytek Biosciences (CTKB) CEO awarded options, RSUs and surrenders shares for taxes - Stock Titan
Cytek Biosciences (CTKB) CFO receives new equity awards and RSU vesting - Stock Titan
Cytek Biosciences (CTKB) CTO granted stock options and 227,535 RSUs - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) director gains 2,908 shares via RSU vesting - Stock Titan
Latest CTKB NewsAmberstone Biosciences Secures $12 Million ... - Stock Titan
Cytek Biosciences, Inc. (CTKB) Stock Analysis: Unveiling a 44% Potential Upside in the Medical Devices Space - DirectorsTalk Interviews
Sell Signal: What is the Moat Score of Cytek Biosciences IncTrade Performance Summary & AI Driven Stock Price Forecasts - baoquankhu1.vn
Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Taiwan News
Cytek Biosciences expands global reach with one year of Singapore operations - Traders Union
Cytek Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - Bitget
Cytek Biosciences Highlights Aurora Evo, Recurring Revenue Growth and 2026 Outlook at TD Cowen Conference - Yahoo Finance
How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance - Yahoo Finance
Cytek Biosciences Balances Growth With Margin Strain - The Globe and Mail
Cytek Biosciences Inc (CTKB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.41%
0.93%
자본화:
|
볼륨(24시간):